Pacific Biosciences of California (PACB) had its best year since October 27, 2010 in 2020, returning 401.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Pacific Biosciences of California (PACB) | 2010 | -3.58% |
Pacific Biosciences of California (PACB) | 2011 | -82.62% |
Pacific Biosciences of California (PACB) | 2012 | -41.38% |
Pacific Biosciences of California (PACB) | 2013 | 198.86% |
Pacific Biosciences of California (PACB) | 2014 | 50.77% |
Pacific Biosciences of California (PACB) | 2015 | 66.62% |
Pacific Biosciences of California (PACB) | 2016 | -70.75% |
Pacific Biosciences of California (PACB) | 2017 | -30.89% |
Pacific Biosciences of California (PACB) | 2018 | 177.15% |
Pacific Biosciences of California (PACB) | 2019 | -30.35% |
Pacific Biosciences of California (PACB) | 2020 | 401.74% |
Pacific Biosciences of California (PACB) | 2021 | -21.46% |
Pacific Biosciences of California (PACB) | 2022 | -60.1% |
Pacific Biosciences of California (PACB) | 2023 | 17.91% |
Pacific Biosciences of California (PACB) | 2024 | -80.29% |
